GHSI(Delisted)
Guardion Health·NASDAQ
--
--(--)
Signals Analysis
Bullish signal 1
Bearish signal 1
EPS Beats Expectation
Revenue Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About GHSI
Guardion Health Sciences, Inc.
A clinical nutrition company that develops, manufactures and sells equipment and supplies for standardized vision testing
2925 Richmond Avenue, Suite 1200, Houston, Texas 77098
--
Guardion Health Sciences, Inc., was founded in December 2009 in California. The Company is a clinical nutrition company that develops and distributes clinically supported nutritional, medical food and dietary supplements. The company offers a range of science-based clinical support products designed to support retail consumers, healthcare professionals and providers and their patients with nutrients such as calcium, vitamin D, vitamin K, carotenoids and Omega-3s to support bone health, eye health, cardiovascular health and brain health. Following the acquisition of Activ, their business efforts shifted to focus on the development and marketing of science-based clinical nutrition and supplements.
Company Financials
EPS
GHSI has released its 2023 Q3 earnings. EPS was reported at 0.29, versus the expected 0, beating expectations. The chart below visualizes how GHSI has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
GHSI has released its 2024 Q2 earnings report, with revenue of 72.92K, reflecting a YoY change of -8.43%, and net profit of 10.32M, showing a YoY change of 980.61%. The Sankey diagram below clearly presents GHSI's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
You can ask Aime
No Data
